颅底脑膜瘤切除术后EQ-5D生活质量分析与成本效果
回顾性分析52例颅底脑膜瘤切除术患者,按术后1个月EQ-5D-3L指数评分分为恶化、不变和改善三组,比较各组成本贡献与总成本,并计算质量调整生命年(QALY)及每QALY成本。
要点
- 术后1个月EQ-5D改善者随访1年持续改善,QALY提高且每QALY成本降低。
- 女性、无突眼、非额颞入路、未行视神经减压及无手术并发症与1年EQ-5D改善相关。
核心结论
- 颅底脑膜瘤切除术后即刻EQ-5D改善的患者在1年时可能持续改善,QALY提高且每QALY成本降低。
研究设计与样本
- 回顾性 review,纳入52例接受颅底脑膜瘤切除术、有充分临床随访并完成术前及术后1个月和1年EQ-5D-3L问卷的患者,分析Value Driven Outcomes数据库的成本数据。
主要发现
- 52例患者(83.0%女性,平均年龄51.9岁)按术后1个月EQ-5D-3L指数评分分为恶化组(n=7)、不变组(n=24)和改善组(n=21)。
- 三组间子类别成本贡献或总成本无差异。
- 改善组在每个随访期持续改善,而不变组和恶化组未持续改善。
- 所有组的平均QALY和每QALY成本均改善,但30天随访时结局较好的患者改善率更高。
- 女性、无突眼、非额颞入路、未行视神经减压及无手术并发症与1年随访时EQ-5D-3L评分改善相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Skull base meningioma management is complicated by their proximity to intracranial neurovascular structures because complete resection may pose a risk of worsening morbidity. OBJECTIVE: To assess the influence of clinical outcomes and surgical management on patient-perceived quality-of-life outcomes, value, and cost-effectiveness. METHODS: Patients who underwent resection of a skull base meningioma, had adequate clinical follow-up, and completed EQ-5D-3L questionnaires preoperatively and at 1 mo and 1 yr postoperatively were identified in a retrospective review. Cost data from the Value Driven Outcomes database were analyzed. RESULTS: A total of 52 patients (83.0% women, mean age 51.9 yr) were categorized by worsened (n = 7), unchanged (n = 24), or improved (n = 21) EQ-5D-3L index scores at 1-mo follow-up. No difference in subcategory cost contribution or total cost was seen in the 3 groups. Patients with improved scores showed a steady improvement through each follow-up period, whereas those with unchanged or worsened scores did not. Mean quality-adjusted life years (QALYs) and cost per QALY improved for all groups but at a higher rate for patients with better outcomes at 30-d follow-up. Female sex, absence of proptosis, nonfrontotemporal approaches, no optic nerve decompression, and absence of surgical complications demonstrated improved EQ-5D-3L scores at 1-yr follow-up. A mean cost per QALY of $27 731.06 ± 22 050.58 was observed for the whole group and did not significantly differ among patient groups (P = .1). CONCLUSION: Patients undergoing resection of skull base meningiomas and who experience an immediate improvement in EQ-5D are likely to show continued improvement at 1 yr, with improved QALY and reduced cost per QALY.
引用
- Karsy M, Jensen MR, Guan J, et al. EQ-5D Quality-of-Life Analysis and Cost-Effectiveness After Skull Base Meningioma Resection. Neurosurgery. 2019. PMID: 30869135. doi:10.1093/neuros/nyz040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。